Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.99M | 10.08M | 10.25M | 10.04M | 9.87M |
| Total Other Revenue | -400.00 | 7.10K | 14.60K | 7.20K | -- |
| Total Revenue | 9.99M | 10.09M | 10.27M | 10.04M | 9.87M |
| Cost of Revenue | 6.31M | 6.42M | 6.59M | 6.45M | 6.33M |
| Gross Profit | 3.69M | 3.67M | 3.68M | 3.60M | 3.53M |
| SG&A Expenses | 6.33M | 6.20M | 6.12M | 5.95M | 5.82M |
| Depreciation & Amortization | 558.60K | 605.60K | 657.70K | 670.90K | 687.20K |
| Other Operating Expenses | 46.10K | 269.00K | 495.30K | 425.40K | 357.80K |
| Total Operating Expenses | 13.24M | 13.50M | 13.86M | 13.50M | 13.20M |
| Operating Income | -3.25M | -3.41M | -3.60M | -3.45M | -3.33M |
| Income Before Tax | -3.89M | -3.76M | -3.65M | -3.57M | -3.50M |
| Income Tax Expenses | -350.60K | -1.34M | -2.37M | -2.37M | -2.37M |
| Earnings from Continuing Operations | -3.54 | -2.41 | -1.28 | -1.19 | -1.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.54M | -2.41M | -1.28M | -1.19M | -1.13M |
| EBIT | -3.25M | -3.41M | -3.60M | -3.45M | -3.33M |
| EBITDA | -2.83M | -3.08M | -3.35M | -3.16M | -2.98M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.02B | 918.93M | 813.04M | 715.63M | 618.21M |
| Average Diluted Shares Outstanding | 1.02B | 918.93M | 813.04M | 715.63M | 618.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |